- In April 2025, BD launched next-generation wearable defibrillators for at-home use in high-risk cardiac patients not eligible for implantable devices. These devices provide continuous monitoring and automatic therapy for life-threatening arrhythmias, enhancing early intervention, expanding treatment options, and potentially improving outcomes for patients at risk of sudden cardiac arrest.
